The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 25, 2011

Filed:

Sep. 28, 2007
Applicants:

Jinhwa Lee, Yongin-si, KR;

Jeong Min Kim, Seoul, KR;

Chong-hwan Jonathan Chang, Yongin-si, KR;

Suk Ho Lee, Suwon-si, KR;

Hee Jeong Seo, Seoul, KR;

Suk Youn Kang, Yongin-si, KR;

Kwang-seop Song, Yongin-si, KR;

Jong Yup Kim, Yongin-si, KR;

Min-ah Kim, Seongnam-si, KR;

Sung-han Lee, Seoul, KR;

Kwang-woo Ahn, Seoul, KR;

Myung Eun Jung, Seongnam-si, KR;

Ji-hyun Park, Seongnam-si, KR;

Inventors:

Jinhwa Lee, Yongin-si, KR;

Jeong Min Kim, Seoul, KR;

Chong-Hwan Jonathan Chang, Yongin-si, KR;

Suk Ho Lee, Suwon-si, KR;

Hee Jeong Seo, Seoul, KR;

Suk Youn Kang, Yongin-si, KR;

Kwang-Seop Song, Yongin-si, KR;

Jong Yup Kim, Yongin-si, KR;

Min-ah Kim, Seongnam-si, KR;

Sung-han Lee, Seoul, KR;

Kwang-Woo Ahn, Seoul, KR;

Myung Eun Jung, Seongnam-si, KR;

Ji-Hyun Park, Seongnam-si, KR;

Assignee:

Green Cross Corporation, Yongin-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/415 (2006.01); A61K 31/4196 (2006.01); C07D 231/10 (2006.01); C07D 285/12 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

A heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CBreceptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The present invention also provides a method for preparing the inventive heteroaryl-pyrasole compounds or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.


Find Patent Forward Citations

Loading…